Biochemotherapy with thymosin alpha1, interleukin-2 and dacarbacine in patients with metastatic melanoma: clinical und immunological effects

Author(s): Carpano, S., Cavaliere, K., di, L. , L, Ameglio, F., Vitelli, G., Frasca, A., Vici, P., Pignatti, F., Rosselli

Journal/Book: Annals of Oncology. 1994; 5: 741-746.